Journal article

BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients

Kenneth Gordon, Kim Papp, Melinda Gooderham, Akimichi Morita, Peter Foley, Diamant Thaçi, Sundeep Kundu, Renata Kisa, Lan Wei, Subhashis Banergee

SKIN The Journal of Cutaneous Medicine | Dermsquared | Published : 2020

DOI: 10.25251/skin.4.supp.28

Download PDF

Abstract

Abstract not available.

University of Melbourne Researchers

Citation metrics

8Dimensions

Keywords

32 Biomedical and Clinical Sciences
Clinical Trials and Supportive Activities
Autoimmune Disease
Psoriasis
3202 Clinical Sciences
6.1 Pharmaceuticals
Dental/oral and Craniofacial Disease
Clinical Research